Day: February 27, 2025

TORONTO, Feb. 27, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is proud to announce that its previously announced (See press release of October 8, 2024) contract to the University of Texas Health Science Center at San Antonio (UT Health San Antonio) will move forward, with the trial having been funded by a grant via the Defense Appropriations Act. “This DoD-funded project has the potential to be a game-changer for the treatment of PTSD in active duty military populations,” said Alan Peterson, PhD, professor of psychiatry and behavioral sciences at UT Health San Antonio and director of the STRONG STAR Consortium. The...

Golar LNG Limited advises that its 2025 Annual General Meeting will be held on Tuesday May 20, 2025.  The record date for voting at the Annual General Meeting is set to March 13, 2025. A copy of the notice, agenda and associated material will be distributed to shareholders by normal distribution methods prior to the meeting and will also be made available on the Company’s website at www.golarlng.com Golar LNG LimitedHamilton, BermudaFebruary 27, 2025 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

BERKELEY HEIGHTS, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (“Cyclacel”) (NASDAQ: CYCC, NASDAQ: CYCCP), a biopharmaceutical company that develops innovative cancer medicines, today announced a change in control and leadership on February 26, 2025. Pursuant to the closing of a Securities Purchase Agreement (the “Agreement”) between Cyclacel’s former interim chief executive officer David Lazar (“Seller”) and Datuk Dr. Doris Wong Sing Ee (“Purchaser”), executed on February 11, 2025, Purchaser purchased from Seller, 1,000,000 shares of Series C Convertible Preferred Stock of Cyclacel, $0.0001 par value per share (the “Series C”) and such number of the 2,100,000 shares of Series D Convertible Preferred Stock of Cyclacel, $0.0001 par value per share (the “Series D”) held by Seller so that Purchaser...

Eric W. Thornburg to retire as Chief Executive Officer and President effective June 30, 2025; will remain on as non-executive Chair of the Board Andrew F. Walters named next Chief Executive Officer Bruce A. Hauk promoted to President Kristen A. Johnson promoted to President of the newly formed Shared Services organizationSAN JOSE, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) — SJW Group (NASDAQ: SJW), one of the nation’s largest investor-owned pure-play water and wastewater utilities, today announced a leadership transition that marks the next phase of the company’s strategic direction and planned growth. After eight years of servant leadership and over 40 years of service to the drinking water profession, Eric W. Thornburg will retire as Chief Executive Officer (CEO) and President of SJW Group on June 30, 2025. He will remain on...

NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) — Virtu Financial (NASDAQ: VIRT), a global leader in electronic market making and liquidity provision, today announced its decision to access InvestorLink’s bespoke risk management platform for small and micro-cap securities. Small and micro-cap securities can present unique challenges such as heightened volatility, lower liquidity, and increased susceptibility to market anomalies. Predicting when these events may occur and understanding potential causes of these circumstances can be difficult and often requires combing through dense information filings to glean insights. InvestorLink has developed a tool to aid market participants in these endeavors that delivers real-time data, that can enable financial institutions to detect irregularities, manage exposures proactively, and promote compliance...

BONITA SPRINGS, Fla., Feb. 27, 2025 (GLOBE NEWSWIRE) — Innovative Food Holdings, Inc. (OTCQB: IVFH) (“IVFH” or the “Company”), a national seller of gourmet specialty foods to professional chefs, is pleased to announce an expansion of its airline business with a new first-class cheese program for a major international airline. This marks the first time IVFH has entered this line of business, providing precision-cut portions that require no additional handling at airline catering stations, streamlining service while maintaining an uncompromising level of quality. The Company expects this new business line to deliver approximately $700K in new, incremental revenue during its first year, before including any upside from additional opportunities this new business line unlocks. Through this new partnership, IVFH will leverage its extensive...

Nasdaq Copenhagen                                                                                    Nikolaj Plads 6 DK-1067 Copenhagen K    Copenhagen, 27 February 2025 ANNOUNCEMENT no.4/2025 Managers’ transactions Pursuant to Article 19 of the market abuse regulation Cemat A/S hereby announces the following information received 27 February 2025.Details of the person discharging managerial responsibilities/person closely associated  Name: Joanna Lucyna Iwanowska-NielsenReason for the notification:  Position/status: Member of the board of directors in Cemat A/SInitial notification/Amendment: InitialDetails of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  Name: Cemat A/SLEI: 213800899MWAZT9KQZ78      Details of the transaction(s): section to be repeated...